| 1 |
Rajesh Y., Biswas A. , Banik P. , Pal I. , Das S. , Borkar S. A., Sardana H. , Saha A. , Das S. K., Emdad L. , Fisher P. B., Mandal M., Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma, Oncotarget, 11, 1097-1108, 2020 |
| 2 |
Ganguly S., Das P. , Das T. K., Ghosh S. , Das S. , Bose M. , Mandal M. , Das A. K., Das N. C., Acoustic cavitation assisted destratified clay tactoid reinforced in situ elastomer-mimetic semi-IPN hydrogel for catalytic and bactericidal application, Ultrasonics Sonochemistry, 2020 |
| 3 |
Rajesh Y., Biswas A. , Kumar U. , Banerjee I. , Das S. , Maji S. , Das S. K., Emdad L. , Cavenee W. K., Mandal M. , Fisher P. B., Lumefantrine, an Antimalarial Drug, Reverses Radiation and Temozolomide Resistance in Glioblastoma, Proceedings of the National Academy of Sciences, 11, 12324-12331, 2020 |
| 4 |
Bharadwaj D., Mandal M., Senescence in Polyploid Giant Cancer Cells: A Road That Leads to Chemoresistance, Cytokine Growth Factor Rev, 52, 68-74, 2020 |
| 5 |
Pradeep N. D., Chaudhuri A. , Yarra . , Jena . , Behara . , Mandal M., Real-time monitoring of photo-activated hydrogen persulfide donor for biological entities, Org. Biomol. Chem, 2019 |
| 6 |
Rajesh Y., A B. , U K. , S D. , Banerjee I. , Banik P. , Bharti R. , Nayak S. , Ghosh S. K., Mandal M, Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma, Biochem Pharmacology, 1-16, 2019 |
| 7 |
Mandal S. M., Sinha T. K., Katiyar A. K., Das S. , Mandal M. , Ghosh S., Existence of Carbon Nanodots in Human Blood, J Nanosci Nanotechnol, 6961-6964, 2019 |
| 8 |
Biswas S., Rajesh Y. , Barman S. , Bera M. , Paul A. , Mandal M. , Pradeep N. D., A dual-analyte probe: hypoxia activated nitric oxide detection with phototriggered drug release ability, Chem Commun, 7940-7943, 2018 |
| 9 |
Sau M. C., Rajesh Y. , Mandal M. , Bhattacharjee M., Copper Catalyzed Regioselective N Alkynylation of Pyrazoles and Evaluation of the Anticancer Activity of Ethynyl Pyrazoles, Chemistryselect, 3511-3515, 2018 |
| 10 |
Sohail S., Jaffery J. A., Biswas K., Jigsaw electrode design for electrowetting devices, Micro & Nano Letters, 1046-4059, 2018 |
| 11 |
Rajesh Y., Biswas A. , Mandal M., Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition, Exp Cell Res., 2017 |
| 12 |
Sarkar S., Konar S. , Nagaprasad, P. , Shashi Rajputl S. , Kumar B. , Rao R. R., Mahanty A. (., Pathak, Paul B. Fisher, P. B., Mandal M, Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment, Langmuir, 7649-7659, 2017 |
| 13 |
Biswas G., Jena B. C., Maiti S. , Samanta P. , Mandal M. , Dhara D., Photoresponsive Block Copolymer Prodrug Nanoparticles as Delivery Vehicle for Single and Dual Anticancer Drugs, ACS Omega, 6677-6690, 2017 |
| 14 |
Bhutia S. K., Behera B. , Mandal M. , Maiti T. K, Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer, Int. J of Cancer, 457-466, 2016 |
| 15 |
Kalita H., Kumar B. P., Konar S. , Tantubay S. , Mahto M. K., Mandal M. , Pathak A., Sonochemically synthesized biocompatible zirconium phosphate nanoparticles for pH sensitive drug delivery application, Materials Science and Engg:C (Mater. for Bio. Appl.), 84-91, 2016 |
| 16 |
Banerjee K., Banerjee S. , Das S. , Mandal M., Probing the potential of apigenin liposomes in enhancing bacterial membrane perturbation and integrity loss, J Colloid Interface Sci., 48-59, 2015 |
| 17 |
Karthik, S., Kumar B. N., Gangopadhyay M. , Mandal M. , Pradeep N. D., A targeted, image-guided and dually locked photoresponsive drug delivery system, Journal of Materials Chemistry B, 728-732, 2015 |
| 18 |
Basak K., Dey G. , Sheet D. , Mahadevappa M. , Mandal M. , Dutta P. K, Probabilistic graphical modeling of speckle statistics in laser speckle contrast imaging for noninvasive and label-free retinal angiography, Conf Proc IEEE Eng Med Biol Soc, 2015 |
| 19 |
Dey G., Bharti R. , Sen R. , Mandal M., Microbial amphiphiles: a class of promising new-generation anticancer agents, , 136-146, 2015 |
| 20 |
Mahata D., Mandal S. M., Mandal M. , Nag A. , Nando G. B., Self-assembled cardanol azo derivatives as antifungal agent with chitin-binding ability, Int J Biol Macromol, 5-11, 2014 |
| 21 |
Choudhury H., Gorain B. , Dey G. , Mandal M. , Pal T. K., Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform, Int J Pharm., 131-143, 2014 |
| 22 |
Sen K., Mandal M., Second generation liposomal cancer therapeutics: transition from laboratory to clinic, Int J Pharm, 28-43, 2013 |
| 23 |
Rajput S., Kumar B. N., Sarkar S. , Fisher P. B., Mandal M., Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer, Plos One, 2013 |
| 24 |
Rajput S., Mandal M., Antitumor promoting potential of selected phytochemicals derived from spices: a review, Eur J Cancer Prev, 205-215, 2012 |
| 25 |
Sarkar S., Mazumdar A. , Dash R. , Sarkar D. , Fisher P. B., Mandal M., ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells, J Cell Physiol, 375-384, 2011 |
| 26 |
Thalukder S., Mandal M. , Kundu S. C, Engineered silk fibroin protein 3D matrices for in vitro tumor model, Biomaterials, 2011 |
| 27 |
Jaganathan S. K., Mandal S. M., Jana S. K., Mandal M., Studies on the phenolic profiling, anti-oxidant and cytotoxic activity of Indian honey: in vitro evaluation, Nat Prod Res, 24, 2010 |
| 28 |
Mandal S. M., Mandal M. , Das A. K., Pati B. R., Ghosh A. K., Stimulation of indoleacetic acid production in a Rhizobium isolate of Vigna mungo, Arch Microbio, 389-393, 2009 |
| 29 |
Mandal S. M., Mandal M. , Pati B. R, Proteomics view of a Rhizobium isolate response to arsenite [As(III)] stress, Acta Microbiol Immunol Hung, 157-167, 2009 |
| 30 |
Kupferman M. E., Mandal M, Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma, J Exp Ther Oncol, 117-127, 2009 |
